Anoikis Patterns in Cervical Cancer: Identification of Subgroups and Construction of a Novel Risk Model for Predicting Prognosis and Immune Response
Frontiers in Bioscience-Landmark · 08.11.2023 · 28 (11)
DOI: 10.31083/j.fbl2811287 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 08.11.2023. Verfasst von Xuesong Xiang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The Obstetrics and Gynecology Hospital of Fudan University, 200090 Shanghai, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fudan University's "Tomorrow Star" Famous Physicians Cultivation Project, Fudan University’s “Tomorrow Star” Famous Physicians Cultivation Project.
Abstract (Originalsprache)
Background
Cervical cancer has high morbidity and intratumor heterogeneity. Anoikis, a form of programmed cell death preventing detached cancer cells from readhering, may serve as a potential prognostic signature for cervical cancer. This study aimed to assess the predictive performance of anoikis patterns in cervical cancer prognosis.
Methods
Differentially expressed anoikis-related genes (DEARGs) were identified between normal and cancer samples using data from the Gene Expression Omnibus database with the elucidation of mutation status and bio-function. Novel anoikis molecular subtypes were defined in The Cancer Genome Atlas (TCGA) cohort with consensus clustering analysis. A multigene prognostic signature was constructed through least absolute shrinkage and selection operator (LASSO) Cox analysis with internal and external validation. The nomogram-based survival probability of cervical cancer over 3 and 5 years was predicted and assessed with calibration, receiver operating characteristic, decision curve analysis, and Kaplan-Meier curves. Additionally, mutation, function, and immune analysis were conducted among different risk groups.
Results
We identified 77 DEARGs between normal and cervical cancer tissues and explored their mutation status and functions. The TCGA cohort could be categorized into two subtypes based on these genes. Furthermore, seven prognostic signature genes were constructed, and the nomogram involving DEARGs and clinicopathological characteristics showed satisfactory predictive performance. Functional analysis indicated that immune-related genes were enriched, and immune status, as well as sensitivity of chemotherapies and targeting drugs, were correlated with the risk model.
Conclusions
Anoikis patterns play important roles in tumor immunity and can be used to predict the prognosis of cervical cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, The Obstetrics and Gynecology Hospital of Fudan University, 200090 Shanghai, China.
- Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, The Obstetrics and Gynecology Hospital, Fudan University, 200011 Shanghai, China.
Förderung
- Fudan University's "Tomorrow Star" Famous Physicians Cultivation Project
- Fudan University’s “Tomorrow Star” Famous Physicians Cultivation Project
Zitieren
APA
Xiang, X., & Ding, J. (2023). Anoikis Patterns in Cervical Cancer: Identification of Subgroups and Construction of a Novel Risk Model for Predicting Prognosis and Immune Response. Frontiers in Bioscience-Landmark, 28(11). https://doi.org/10.31083/j.fbl2811287
Vancouver
Xiang X, Ding J. Anoikis Patterns in Cervical Cancer: Identification of Subgroups and Construction of a Novel Risk Model for Predicting Prognosis and Immune Response. Frontiers in Bioscience-Landmark. 2023;28(11). doi:10.31083/j.fbl2811287
BibTeX
@article{Xiang2023,
author = {Xiang, Xuesong and Ding, Jingxin},
title = {Anoikis Patterns in Cervical Cancer: Identification of Subgroups and Construction of a Novel Risk Model for Predicting Prognosis and Immune Response},
journal = {Frontiers in Bioscience-Landmark},
year = {2023},
volume = {28},
number = {11},
doi = {10.31083/j.fbl2811287}
}
EUVIMED